Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 2,274 shares at $238.72 ($545K) on 2021-08-31, disclosed to the SEC on 2021-09-01.
Open-market sale of $545k NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $234.64 | 53 | $12K | 2.3% |
| 2 | $237.14 | 108 | $26K | 4.7% |
| 3 | $238.72 | 320 | $76K | 14.0% |
| 4 | $238.72 | 320 | $76K | 14.0% |
| 5 | $239.66 | 359 | $86K | 15.8% |
| 6 | $239.66 | 359 |
| $86K |
| 15.8% |
| 7 | $240.58 | 175 | $42K | 7.7% |
| 8 | $241.59 | 209 | $50K | 9.3% |
| 9 | $241.59 | 209 | $50K | 9.3% |
| 10 | $242.63 | 100 | $24K | 4.4% |
| 11 | $244.03 | 62 | $15K | 2.8% |
| Total | $239.83 avg | 2,274 | $545K | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |